Survival outcomes
At the cutoff date of April 8, 2022, median follow-up times were 13.9 (range 1.0–20.9) months for disease-free survival (DFS) and 18.2 (range, 7.0–32.4) months for event-free survival (EFS) and OS. The survival of patients with different treatment responses is summarized in Fig. 